Level of transforming growth factor beta 1 is elevated in cerebrospinal fluid of children with acute bacterial meningitis

Journal of Neurology

Volumn 244, Issue 10, 1997, Pages 634-638

  Huang, Chao Ching ^a   Chang, Ying Chao ^b   Chow, Nan Haw ^a   Wang, Shan Tair ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b Kaohsiung Chang Gung Children's H ^*  (Taiwan)

Author keywords

Bacterial meningitis; Cerebrospinal fluid; Transforming growth factor beta 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; ASEPTIC MENINGITIS; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID CYTOLOGY; CEREBROSPINAL FLUID LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HUMAN; INFANT; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL;

ACUTE DISEASE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MENINGITIS, ASEPTIC; MENINGITIS, BACTERIAL; PROGNOSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030687922     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050159     Document Type: Article

References (25)

1. Arditi M, Manogue KR, Caplan M, Yogev R (1990) Cerebrospinal fluid cachectin/tumor necrosis factor-α and platelet-activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis 162:139-147
2. Banati R, Graeber MB (1994) Surveillance, intervention and cytotoxicity: is there a protective role of microglia? Dev Neurosci 16:114-127
3. Dulkerian SJ, Kilpatrick L, Costarino AT, et al (1995) Cytokine elevations in infants with bacterial meningitis and aseptic meningitis. J Pediatr 126:872-876
4. Espevik T, Figari IS, Shalaby MR, et al (1987) Inhibition of cytokine production by cyclosporin A and transforming-growth-factor-beta. J Exp Med 166:571-576
5. Fontana A, Constam DB, Frei K, Malipiero U, Pfister HW (1992) Modulation of the immune response by transforming growth factor beta. Arch Allergy Immunol 99:1-7
6. Gamble JR, Vadas MA (1988) Endothelial adhesiveness for blood neutrophils in inhibited by transforming growth factor β. Science 242:97-100
7. Guerra-Romero L, Tureen JH, Fournier MA, Makrides V, Tauber M (1993) Amino acids in cerebrospinal fluids and brain interstitial fluid in experimental pneumococcal meningitis. Pediatr Res 33:510-513
8. Herson VC, Todd JK (1977) Prediction of morbidity in Hemophilus influenzae meningitis. Pediatrics 59:35-39
9. Johnson MD, Gold LI, Moses HL (1992) Evidence for transforming growth factor-β expression in human leptomeningeul cells and transforming growth factor-β-like activity in human cerebrospinal fluids. Lab Invest 67:360-368
10. Korsching S (1993) The neurotrophic factor concept: a reexamination. J Neurosci 13:2739-2748
11. Krupinski J, Kumar P, Kumar S, Kaluza J (1996) Increased expression of TGF-β1 in brain tissue after ischemic stroke in humans. Stroke 27:852-857
12. Mattson MP, Scheff SW (1994) Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implication of therapy. J Neurotrauma 11:3-33
13. Motohashi O, Suzuki M, Yanai N, Umezawa K, Shida N, Yoshimoto T (1995) Thromhin and TGF-β promote human leptomeningeal cell proliferation in vitro. Neurosci Lett 190:105-108
14. Ossege LM, Voss B, Wiethege T, Sindern E, Malin JP (1994) Detection of transforming growth factor betal mRNA in cerebrospinal fluid cells of patients with meningitis by non-radioactive in situ hybridization. J Neurol 242:14-19
15. Pfister HW, Frei K, Ottnad B, Koedel U, Tomasz A, Fontana A (1992) Transforming growth factor β2 inhibits cerebrospinal changes and brain edema formation in the tumor necrosis factor α-independent early phase of experimental pneumococcal meningitis. J Exp Med 176:265-268
16. Pfister HW, Fontana A, Tauber MG, Tomasz A, Scheld WM (1994) Mechanisms of brain injury in bacterial meningitis: workshop summary. Clin Infect Dis 19:463-479
17. Prehn JHM, Bindoka VP, Marcuccilli CJ, Krajewski S, Reed JC, Miller RJ (1994) Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type β confers wide-ranging protection on rat hippocampul neurons. Proc Natl Acad Sci USA 91:12599-12603
18. Quagliarello V, Scheld WM (1992) Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med 327:864-872
19. Rutka JT, Giblin JR, Dougherty DV, McCulloch JR, DeArmond SJ, Rosenblum ML (1986) An ultrastructural and immunocytochemical analysis of leptomeningeal and meningioma cultures. J Neuropathol Exp Neurol 45:285-303
20. Saez-Llorens X, Ramilo O, Mustafa MM, Mertsola J, McCracken GH (1990) Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. J Pediatr 116:671-684
21. Spranger M, Schwab S, Krempien S, Winterholler M, Steiner T, Hacke W (1996) Excess glutamate levels in the cerebrospinal fluid predict clinical outcome of bacterial meningitis. Arch Neurol 53:992-996
22. Tsunawaki S, Sporn M, Ding A, Nathan C (1988) Deactivation of macrophage by transforming growth factor-β. Nature 334:260-263
23. Turner M, Chantry D, Kalsikis P, Berger A, Brennan FM, Feldmann M (1991) Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β. Eur J Immunol 21:1635-1639
24. Van Furth AM, Seijmonsbergen EM, Langermans JAM, Groeneveld PHP, Bel CE del, Van Furth R (1995) High levels of interleukin 10 and tumor necrosis factor β in cerebrospinal fluid during the onset of bacterial meningitis. Clin Infect Dis 21:220-222
25. Wahl SM (1992) Transforming growth factor beta in inflammation: a cause and a cure. J Clin Immunol 12:61-74